Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Network.
Press releases published on May 16, 2025
Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen
GlobeNewswire
·
May 16, 2025
Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente sichergestellt und die Produktion in Europa gefördert werden sollen. …
Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …
Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché
GlobeNewswire
·
May 16, 2025
VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …
GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase
GlobeNewswire
·
May 16, 2025
Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …
BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement
GlobeNewswire
·
May 16, 2025
XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …
Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform
GlobeNewswire
·
May 16, 2025
WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …
Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.
GlobeNewswire
·
May 16, 2025
VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 16, 2025
SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award
GlobeNewswire
·
May 16, 2025
MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …
Replimune Announces Dates for Fiscal Fourth Quarter and Year End 2025 Financial Results and Upcoming Investor Day
GlobeNewswire
·
May 16, 2025
WOBURN, Mass., May 16, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that it will host a conference call on Thursday, May …
Spectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that management will participate in a …
NexGold Infill Drilling Intersects New Zones of Gold Mineralization at the Goldboro Gold Project
GlobeNewswire
·
May 16, 2025
TORONTO, May 16, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000 metre diamond drill program initially announced on January 22, 2025 at the Company’ …
Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting
GlobeNewswire
·
May 16, 2025
Company Urges Stockholders to Vote ‘FOR’ Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Support Proposal #2 SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE …
GDEV announces results for the first quarter of 2025
GlobeNewswire
·
May 16, 2025
LIMASSOL, Cyprus, May 16, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its financial and operational results for the first quarter ended March 31, 2025. First …
Bitget Wallet First to Integrate Believe Launch Platform For Early Token Trading
GlobeNewswire
·
May 16, 2025
SAN SALVADOR, El Salvador, May 16, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has become the first wallet to integrate direct trading support for all tokens launched on Believe, a fast-growing token launch platform. …
Paratek Pharmaceuticals to Present Clinical Data on NUZYRA® (omadacycline) at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
May 16, 2025
First conference presentations for: Phase 2b study for nontuberculous mycobacterial pulmonary disease (NTM PD) caused by Mycobacterium abscessus complex (MABc) Phase 3 OPTIC-2 study in moderate-to-severe community-acquired bacterial pneumonia (CABP) BOSTON …
BioCryst Presents New Real-world Evidence Showing Significant and Sustained Reductions in HAE Attack Rates in Adolescents and People with Severe HAE Following Initiation of ORLADEYO® (berotralstat)
GlobeNewswire
·
May 16, 2025
RESEARCH TRIANGLE PARK, N.C., May 16, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO® (berotralstat) in adolescents and people with severe HAE showing …
Bitget Gains Market Share in April 2025 Monthly Report Highlights
GlobeNewswire
·
May 16, 2025
VICTORIA, Seychelles, May 16, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, released its April 2025 Transparency Report, highlighting a month of growth, regulatory milestones, and continued momentum despite broader …
MEXC Announces Einstein (EIN) Listing in July, 50 Million EIN Rewards Event Launches Now
GlobeNewswire
·
May 16, 2025
VICTORIA, Seychelles, May 16, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has announced that it will list Einstein (EIN) on July 20, 2025 (UTC). Ahead of the listing, MEXC will launch two exclusive events this May with a total …
Bitget Wallet Surpasses 80 Million Users Amid Rising Demand for Self-Custody
GlobeNewswire
·
May 16, 2025
SAN SALVADOR, El Salvador, May 16, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has surpassed 80 million users globally, marking a major milestone in its seventh year of operations. The sharp growth reflects a broader …